You have read all your free articles, to continue reading subscribe to read the rest of this content.
Oncorena has announced the initiation of the Phase I-II clinical trial of orellanine in patients with advanced kidney cancer on dialysis. The drug candidate orellanine is being developed for organ-specific chemotherapy with curative potential for patients with advanced kidney cancer undergoing diAlready a subscriber Login You have read all your…
Novo Nordisk has announced that a peer-reviewed journal published the results of a phase 3 trial evaluating the investigational use of Saxenda in adolescents with obesity. The study was accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting in San Francisco, US, and willAlready a subscriber Login You…
Calliditas Therapeutics has announced positive topline results from Part A of the global Phase 3 clinical trial NefIgArd, which investigated the effect of Nefecon versus placebo in patients with primary IgA nephropathy (IgAN). The trial met its primary objective of demonstrating a statistically sAlready a subscriber Login You have read…
A study conducted at Lund University by lead researcher Charlotte Erlanson-Albertsson, MD, PhD found that people who were trying to lose weight and used the spinach extract Appethyl daily lost more than 40 percent more weight than those who took a placebo. In this clinical trial, overweight womeAlready a subscriber Login…
